Primary and Secondary Ventral Hernia
Conditions
Keywords
ventral hernia
Brief summary
Since abdominal wall hernia repair is currently performed with the use of a mesh, side effects associated with the mesh are frequently reported during long term follow-up. These side effects are related to shrinkage of the mesh, adhesions to the bowl, pain, and inflammation of the skin and bowl. To reduce or prevent these effects, a fully resorbing mesh has been developed, which provides sufficient support and strength to allow efficient recovery of the abdominal wall, but also disappear from your body in three years time, so that you no longer have any synthetic material in your body. Previous resorbing meshes also disappeared but over a much shorter period of time, so that the hernia was insufficiently healed, with recurrence as a result. The TIGR™ mesh (the resorbable mesh used in the study) is in principle a synthetic mesh, made of two commonly used polymers, however it will retain 50% of its initial strength after six months. This in theory is enough to provide support of the collagen healing process during the initial wound-healing phase, but also to support the transition of initial collagen to functional collagen. The aim of this study is to compare TIGR™ with large pore mesh used in the repair of the anterior abdominal wall repair (incisional hernia, umbilical hernia, etc..Inguinal hernias are not part of the study). Therefore the patients will be divided into two groups, one group will be treated with a resorbing mesh, the other group will be treated with a permanent mesh. Otherwise there will be no difference in the medication or the surgical techniques used.
Interventions
Surgery for primary and secondary ventral hernia repair with placing of resorbable mesh.
Surgery for primary and secondary ventral hernia repair with placing of non-resorbable synthetic mesh.
Sponsors
Study design
Eligibility
Inclusion criteria
* Primary and secondary ventral hernia * less than 20 cm in length * less than 6 cm in width
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recurrence rate at 3 years post-surgery. | 3 years post-surgery | Clinical evaluation and ultrasound evaluation after 3 years post-surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Wound Morbidity 4 weeks post-surgery. | 4 weeks post-surgery | — |
| Pain and discomfort after 1 year post-surgery. | After 1 year post-surgery | — |
| Pain and discomfort after 3 years post-surgery. | After 3 years post-surgery | — |
| Recurrence rate by clinical examination 1 year post-surgery. | After 1 year post-surgery. | Clinical Examination to determine the recurrence rate. |
Countries
Belgium, Denmark, Poland, Spain, United Kingdom